A08356 Summary:

BILL NOA08356A
 
SAME ASNo Same As
 
SPONSORWeprin
 
COSPNSR
 
MLTSPNSR
 
Amd 19.07, Ment Hyg L
 
Requires the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of Ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Go to top    

A08356 Actions:

BILL NOA08356A
 
08/05/2015referred to alcoholism and drug abuse
01/06/2016referred to alcoholism and drug abuse
04/11/2016amend and recommit to alcoholism and drug abuse
04/11/2016print number 8356a
Go to top

A08356 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A8356A
 
SPONSOR: Weprin
  TITLE OF BILL: An act to amend the mental hygiene law, in relation to requiring the office of alcoholism and substance abuse services to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment   PURPOSE: To encourage and fund clinical research examining Ibogaine as a possible pharmacotherapy that would suppress the craving for cocaine, methamphe- tamine, and heroin quickly and at a lower cost than current treatment methods.   SUMMARY OF PROVISIONS: The bill amends section 19.07 of the Mental Hygiene Law and requires the Division of Substance Abuse Services to encourage, aid, and facilitate clinical research into the use of Ibogaine in drug treatment.   RATIONALE: Like many other states, New York has seen significant impact from the current heroin and cocaine epidemic in America. Among the most promising treatments in development is Ibogaine, a medication derived from an African botanical which has been shown to eliminate narcotic withdrawal and interrupt self-administration of drugs of abuse. Over the past 20 years, thousands of American addicts have traveled to Mexican clinics for treatment with Ibogaine. Returning addicts report they experienced no withdrawal symptoms and that cravings to use drugs were absent. Dr. Kenneth Alper of New York University reported the emer- gence of Ibogaine as a part of a growing medical subculture. (Journal of Ethno-Pharmacology, 115: pp 924).   JUSTIFICATION: New York researchers have taken the lead in conducting research evaluat- ing Ibogaine. The Chairman of the Depaitment of Pharmacology of Albany Medical College, Dr. Stanley Glick, reported that Ibogaine eliminated acute signs of opiate withdrawal in the animal model (Neuropharmacology 31: 5 pp. 497-500). He further reported that it also interrupted self- administration of morphine (European Journal of Pharmacology, 195:pp 341-345) as well as cocaine self-administration (Brain Research, 657: pp 14-22). Dr. Henry Sershen of the Nathan Klein Institute of Psychiatric Research in Orangeburg, NY reported that Ibogaine reduces preference for cocaine consumption (Pharmacology Biochemistry and Behavior, 46:pp 942-948). Dr. Patricia Broderick of the City University of New York Medical School, Department of Pharmacology, demonstrated that the effects of Ibogaine are consistent with current views regarding rational strategies for cocaine treatment. NIDA Research Monograph Series 119.   FISCAL IMPLICATIONS: To be determined.
Go to top

A08356 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         8356--A
 
                               2015-2016 Regular Sessions
 
                   IN ASSEMBLY
 
                                     August 5, 2015
                                       ___________
 
        Introduced by M. of A. WEPRIN -- read once and referred to the Committee
          on  Alcoholism and Drug Abuse -- recommitted to the Committee on Alco-
          holism and Drug Abuse in accordance with Assembly Rule 3,  sec.  2  --
          committee  discharged,  bill amended, ordered reprinted as amended and
          recommitted to said committee

        AN ACT to amend the mental hygiene law, in  relation  to  requiring  the
          office  of  alcoholism and substance abuse services to encourage, aid,
          and facilitate clinical research into the  use  of  ibogaine  in  drug
          treatment
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Section 19.07 of the  mental  hygiene  law  is  amended  by
     2  adding a new subdivision (l) to read as follows:
     3    (l)  The  office  of  alcoholism  and  substance  abuse services shall
     4  encourage, aid,  and  facilitate  clinical  research  into  the  use  of
     5  ibogaine  in  drug  treatment  for  heroin,  methamphetamine and cocaine
     6  addiction.
     7    § 2. This act shall take effect immediately.
 
 
 
 

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11708-02-6
Go to top